Trial Profile
Safety and Efficacy Study of Bimatoprost/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 14 Nov 2014
Price :
$35
*
At a glance
- Drugs Bimatoprost/timolol (Primary)
- Indications Ocular hypertension
- Focus Therapeutic Use
- Sponsors Allergan
- 14 Nov 2014 New trial record